Sinofn Health
Sinofn Health
Discover our cutting-edge health nutrition formulations backed by scientific rigor and top-tier technological infrastructure.
Empowering global wellness brands through elite academic collaboration and state-of-the-art manufacturing excellence.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group ā a national high-tech enterprise founded in 2012 and backed by the prestigious Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the premier trading hub for global partners seeking premium, science-driven contract manufacturing services.
We combine deep biochemical expertise, state-of-the-art automated production lines, and an uncompromised commitment to product efficacy. Our mission is to accelerate the success of international brands by transforming innovative nutritional concepts into market-ready realities.
Rooted in clinical empathy, driven by scientific breakthrough.
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children ā where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
Her commitment attracted strategic investors and fueled transformative growth:
"We measure success not just in revenue, but in lives improved through accessible science." ā Mrs. GuoHong Liu, Founder
Through cooperation with top universities and internal team building, SINOFN has established a professional scientific research elite team.
The team is led by Dr. Zhang Ying, Postdoctoral Fellow and Associate Researcher, Chinese Academy of Sciences, and Dr. Tan Shengjie, Director of SINOFN Medical Innovation Department and Peking University Medical Doctor, leading the research and development of the company's strategic products and functional foods.
Mr. Hans, a specially appointed expert from the Netherlands, serves as the chief engineer, leading the development and industrialization of special medical foods and special dietary foods. Other team members include doctoral candidates, master's candidates, laboratory technicians, and process technicians.
Dr. Tan Shengjie
Ph.D Peking University Medical School
15+ years in metabolic disorder formulations
Dr. Zhang Ying
Associate Researcher, CAS Postdoc
Specialist in bioactive compound delivery systems
Hans van Dijk
Senior Scientist (Netherlands)
EU regulatory specialist in nutraceutical delivery tech
Advanced manufacturing infrastructure delivering over 500 million units annually with global quality compliance.
10+ dedicated lines (softgels, gummies, powders)
ISO 22000, HACCP, FSSC 22000 certified
Annual capacity: 500M+ units
HPLC/GC-MS contaminant screening
Microbiological safety testing
Stability and dissolution validation
Pilot-scale prototyping for tablets/capsules/liquids
Bioavailability optimization studies
Stability testing chambers
Raw material storage ā Production ā Packaging
Blockchain batch tracking
BRCGS-certified warehousing
Solid scale, robust capabilities, and verified industry leadership.
Navigating the next decade of nutraceutical innovation, supply chain resilience, and global compliance.
As consumer demand shifts towards targeted cellular longevity and personalized nutrition, SINOFN is pioneering advanced delivery systems. Our R&D collaboration with the Chinese Academy of Sciences focuses on liposomal encapsulation, nano-emulsion technologies, and sustained-release microencapsulation. These mechanisms dramatically increase the systemic bioavailability of sensitive active compounds such as NMN, PQQ, and peptide complexes, ensuring superior efficacy for end-users.
Global supplement brands face stringent regulatory hurdles, volatile raw material costs, and aggressive time-to-market pressures. SINOFN resolves these challenges by offering comprehensive turnkey solutionsāfrom custom formulation design and pilot-scale prototyping to full-scale commercial manufacturing and blockchain-verified batch tracking. Our macro-level supply chain resilience ensures consistent inventory flow and uncompromised quality assurance across international borders.
Navigating global compliance requires deep regulatory insight. With formulation and compliance experts spanning China, Europe (Netherlands), and North America, SINOFN bridges regional standards. We ensure that every product batch meets or exceeds FDA, EFSA, ISO22000, HACCP, and HALAL requirements, facilitating seamless market entry for global brand partners.
Our smart manufacturing infrastructure leverages IoT-driven automated production lines, AI-powered quality inspection, and automated warehousing systems. This Industry 4.0 upgrade minimizes human error, optimizes energy consumption, and reduces production lead times by 30%, passing substantial cost efficiencies and superior quality control directly to our global clients.
Explore our specialized functional blends, plant extracts, and medical nutrition manufacturing solutions.
Uncompromising commitment to quality, safety, and regulatory compliance.
Sinofn prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. We are certified with ISO9001, ISO22000, HACCP, FSSC22000, and HALAL, demonstrating our rigorous dedication to global product excellence and food safety.
Everything you need to know about partnering with SINOFN for your OEM/ODM supplement needs.
Our corporate headquarters and global trading hub are located in Shanghai, while our advanced R&D center is in Tianjin (backed by the Chinese Academy of Sciences). Our GMP-certified manufacturing facilities span over 53,000 square meters, serving brand partners across North America, Europe, Asia-Pacific, and beyond.
Yes. Our expert formulation teamāled by CAS researchers and European food scientistsāoffers pilot-scale trial runs, bioavailability testing, and rapid prototyping for capsules, tablets, liquids, powders, and gummies.
Yes; we offer tailored scopes and flexible minimum order quantities (MOQs) designed to support emerging entrepreneurial brands as well as established multinational enterprise portfolios.
